Cooper Pre-Tax Profit Margin 2006-2018 | COO

Current and historical pre-tax profit margin for Cooper (COO) from 2006 to 2018. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Cooper pre-tax profit margin for the twelve months ending April 30, 2018 was $0.058B. Cooper pre-tax profit margin for the three months ending April 30, 2018 was $0.009B, representing a 59.19% decline from the same quarter last year.
Cooper Annual Pre-Tax Profit Margin
2017 18.42
2016 15.03
2015 11.99
2014 17.26
2013 19.67
2012 19.06
2011 14.48
2010 10.74
2009 10.63
2008 7.06
2007 0.07
2006 8.54
2005 13.45
Cooper Quarterly Pre-Tax Profit Margin
Q2 2018 8.55
Q1 2018 12.68
Q4 2017 17.22
Q3 2017 19.37
Q2 2017 20.96
Q1 2017 16.05
Q4 2016 13.28
Q3 2016 18.15
Q2 2016 17.07
Q1 2016 11.28
Q4 2015 8.00
Q3 2015 9.66
Q2 2015 15.41
Q1 2015 15.16
Q4 2014 7.45
Q3 2014 21.82
Q2 2014 21.30
Q1 2014 19.62
Q4 2013 14.83
Q3 2013 22.15
Q2 2013 20.56
Q1 2013 21.32
Q4 2012 20.85
Q3 2012 18.88
Q2 2012 18.19
Q1 2012 18.02
Q4 2011 17.42
Q3 2011 13.98
Q2 2011 12.21
Q1 2011 13.99
Q4 2010 17.19
Q3 2010 14.77
Q2 2010 0.86
Q1 2010 9.39
Q4 2009 11.30
Q3 2009 7.95
Q2 2009 11.76
Q1 2009 11.73
Q4 2008 11.62
Q3 2008 6.29
Q2 2008 6.15
Q1 2008 3.91
Q4 2007 -7.58
Q3 2007 5.20
Q2 2007 -0.17
Q1 2007 3.09
Q4 2006 6.17
Q3 2006 10.76
Q2 2006 7.38
Q1 2006 9.78
Q4 2005 6.28
Q3 2005 16.61
Q2 2005 16.34
Q1 2005 15.15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.431B $2.139B
The Cooper Companies, Inc. is a global medical device company. Cooper is dedicated to being A Quality of Life Company with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women's health, fertility and diagnostics.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $67.166B 24.05
Align Technology (ALGN) United States $28.148B 75.04
McKesson (MCK) United States $25.255B 9.67
AmerisourceBergen (ABC) United States $18.416B 13.38
Laboratory Of America Holdings (LH) United States $18.262B 16.80
Cardinal Health (CAH) United States $15.612B 10.47
Henry Schein (HSIC) United States $12.012B 20.48
West Pharmaceutical Services (WST) United States $8.449B 43.68
DENTSPLY SIRONA (XRAY) United States $8.442B 14.77
Merit Medical Systems (MMSI) United States $3.098B 40.72
Patterson (PDCO) United States $2.200B 13.77
CONMED (CNMD) United States $2.153B 36.47
STAAR Surgical (STAA) United States $1.828B 244.71
Atrion (ATRI) United States $1.239B 36.74
Invacare (IVC) United States $0.548B 0.00
Antares Pharma (ATRS) United States $0.499B 0.00
Endologix (ELGX) United States $0.204B 0.00
Lifevantage (LFVN) United States $0.134B 18.86
Aceto (ACET) United States $0.099B 4.04
Biolase (BIOL) United States $0.033B 0.00
Pro-Dex (PDEX) United States $0.029B 12.79
Milestone Scientific (MLSS) United States $0.025B 0.00
Retractable Technologies (RVP) United States $0.025B 0.00